Long-term follow-up after laparoscopic management of endometrial cancer: a 15-year cohort study

Table 4 Recurrence site and time to recurrence among 21 patients who relapsed

Case	1988 FIGO stage/grade	Recurrence site(s)	Time to recurrence (months)	Status
1	IbG3 (clear cell)	Peritoneal carcinomatosis	7	Deceased
2	IIIaG3, (+) cytology, (+) adnexa	Vagina	143	Alive
3	IIaG1	Vagina + central pelvis	58	Alive
4	IcG1	Aortic lymph nodes + liver + lungs	61	Alive
5	IIIaG1, (+) cytology	Central pelvis + bone	12	Deceased
6	IIIaG1, (+) cytology	Vagina + lungs	9	Deceased
7	IcG1	Liver + lungs	84	Alive
8	IbG1	Lungs	45	Deceased
9	IIIaG1, (+) cytology	Peritoneum	24	Deceased
10	IbG1	Central pelvis	42	Deceased
11	IaG1	Vagina	22	Alive
12	IbG2	Lungs	37	Deceased
13	IIIaG1, (+) cytology	Bone	15	Alive
14	IIIaG3, (+) cytology	Liver + lungs	13	Deceased
15^a	IIIaG3 (clear cells), (+) adnexa	Aortic lymph nodes + liver	6	Deceased
16^a,b	IIIcG1	Aortic lymph nodes	6	Alive
17	IaG1	Vagina + peritoneum	13	Deceased
18	IcG1	Central pelvis + aortic lymph nodes + lungs	29	Deceased
19	IbG3	Central pelvis	45	Alive
20	IcG3	Peritoneum	22	Deceased
21	IIIaG3, (+) cytology	Peritoneum + liver + lungs	16	Deceased

^aProbably presence of metastatic disease at time of surgery. Clinically understaged
^bPara-aortic lymphadenectomy not performed. False (−) frozen section of pelvic nodes